MedTrace Logo

Chronic Subdural Hematoma Embolization With Detachable Coils

NCT07291427 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2026-03-10

No results posted yet for this study

Summary

This is a prospective, multi-center, post market registry study designed to evaluate the safety and efficacy of treatment with Balt coils in patients with chronic subdural hematoma (cSDH).

Conditions

  • Chronic Subdural Hemorrhage (cSDH)

Interventions

DEVICE

Balt coils: (Balt USA, LLC)

MMA embolization utilizing Balt Coils

PROCEDURE

MMA embolization

surgical or bedside evacuation pre or post-surgical debridement

Sponsors & Collaborators

Principal Investigators

  • Christopher Kellner · Icahn School of Medicine at Mount Sinai

  • Benjamin Yim · John Muir Health

  • Alexander Coon · Carondelet Neurological Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-01
Primary Completion
2028-09-01
Completion
2028-09-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07291427 on ClinicalTrials.gov